Clinical and Molecular Epidemiology of Invasive Group B Streptococcus Disease among Infants, China

Emerg Infect Dis. 2019 Nov;25(11):2021-2030. doi: 10.3201/eid2511.181647.

Abstract

Invasive group B Streptococcus (GBS) remains a leading cause of illness and death among infants globally. We conducted prospective and retrospective laboratory-based surveillance of GBS-positive cultures from infants <3 months of age in 18 hospitals across China during January 1, 2015-December 31, 2017. The overall incidence of GBS was 0.31 (95% CI 0.27-0.36) cases/1,000 live births; incidence was 0-0.76 cases/1,000 live births across participating hospitals. The case-fatality rate was 2.3%. We estimated 13,604 cases of GBS and 1,142 GBS-associated deaths in infants <90 days of age annually in China. GBS isolates were most commonly serotype III (61.5%) and clonal complex 17 (40.6%). Enhanced active surveillance and implementation of preventive strategies, such as maternal GBS vaccination, warrants further investigation in China to help prevent these infections.

Keywords: China; Group B Streptococcus; bacteria; clonal complex; epidemiology; incidence; infants; sequence type; serotype; streptococci.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Child, Preschool
  • China / epidemiology
  • Geography, Medical
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Molecular Epidemiology
  • Molecular Typing
  • Public Health Surveillance
  • Serotyping
  • Streptococcal Infections / epidemiology*
  • Streptococcal Infections / microbiology*
  • Streptococcus agalactiae / classification*
  • Streptococcus agalactiae / genetics*